Exazym® White Paper

Measurements of low abundance biomolecules, including proteins and nucleic acids, remain a critical challenge in many biomarker discovery and diagnostic applications due to insufficient sensitivity. But what if you were able to amplify true signal by 10 to 100 times with no extra equipment and only minor changes to your process? That is exactly what Exazym^® does.

In this white paper we share our most recent research which demonstrates how Exazym^®, our unique BOLD immunoassay signal amplification method, is capable of achieving levels of sensitivity that exceed those produced by expensive closed systems while maintaining selectivity.

Exazym^® works with any standard immunoassay and requires no investment in new equipment. As such, it has the potential to make world-class immunoassay amplification accessible to all researchers. Our hope is that this will accelerate the progress of translational research, health screens, and diagnostics testing across a broad range of therapeutic areas, including oncology, neurology, cardiology, inflammation, and infectious disease.

We invite you to download this white paper to learn more about this game-changing amplification method.